Delta Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Sell
8,019
-82
-1% -$2.18K 0.04% 242
2025
Q4
$202K Sell
8,101
-1,401
-15% -$35.3K 0.04% 271
2025
Q3
$242K Sell
9,502
-273
-3% -$6.74K 0.04% 245
2025
Q2
$237K Buy
9,775
+618
+7% +$14.4K 0.05% 215
2025
Q1
$232K Sell
9,157
-277
-3% -$7.25K 0.05% 217
2024
Q4
$250K Sell
9,434
-57
-0.6% -$1.55K 0.05% 217
2024
Q3
$275K Sell
9,491
-152
-2% -$4.43K 0.06% 197
2024
Q2
$270K Buy
9,643
+266
+3% +$7.32K 0.06% 175
2024
Q1
$260K Sell
9,377
-2,384
-20% -$66.2K 0.06% 182
2023
Q4
$339K Sell
11,761
-925
-7% -$28K 0.08% 140
2023
Q3
$421K Buy
12,686
+903
+8% +$31.9K 0.12% 106
2023
Q2
$432K Sell
11,783
-536
-4% -$20.9K 0.12% 106
2023
Q1
$503K Sell
12,319
-841
-6% -$36.3K 0.14% 90
2022
Q4
$674K Buy
13,160
+1,536
+13% +$73.6K 0.22% 73
2022
Q3
$509K Buy
11,624
+5,614
+93% +$273K 0.22% 80
2022
Q2
$315K Buy
6,010
+251
+4% +$12.8K 0.14% 97
2022
Q1
$298K Buy
5,759
+562
+11% +$29.2K 0.09% 112
2021
Q4
$307K Sell
5,197
-998
-16% -$49.4K 0.09% 141
2021
Q3
$266K Sell
6,195
-356
-5% -$15.8K 0.08% 145
2021
Q2
$257K Buy
6,551
+2
+0% +$78 0.08% 151
2021
Q1
$237K Sell
6,549
-357
-5% -$12.7K 0.08% 144
2020
Q4
$254K Sell
6,906
-615
-8% -$22.6K 0.08% 157
2020
Q3
$261K Buy
7,521
+720
+11% +$25.2K 0.14% 97
2020
Q2
$211K Buy
6,801
+45
+0.7% +$1.53K 0.09% 130
2020
Q1
$209K Sell
6,756
-1,223
-15% -$41.7K 0.16% 81
2019
Q4
$296K Buy
7,979
+1,402
+21% +$49.9K 0.11% 103
2019
Q3
$224K Buy
6,577
+114
+2% +$4.14K 0.12% 98
2019
Q2
$265K Buy
+6,463
New +$257K 0.15% 68

Other funds holding PFE

Delta Investment Management's PFE Position: Q1 2026 in Review

Delta Investment Management reduced its Pfizer (PFE) stake by 1% in Q1 2026, selling an estimated $2.18K and leaving 8,019 shares worth $225K. The position accounts for 0.04% of the portfolio, ranked #242.

Delta Investment Management first reported a position in PFE in Q2 2019 and has held it in 28 quarters since. The position peaked at $674K in Q4 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Delta Investment Management held 8,019 shares of Pfizer worth $225K as of Q1 2026.
  • Delta Investment Management sold 82 Pfizer shares in Q1 2026, an estimated $2.18K.
  • Pfizer made up 0.04% of Delta Investment Management's portfolio in Q1 2026, its #242 holding.
  • Delta Investment Management first reported a position in Pfizer in Q2 2019 and has held it in 28 quarters since.
  • Delta Investment Management's Pfizer position peaked at $674K in Q4 2022.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Delta Investment Management's 13F filing for Q1 2026, filed 13 May 2026.